- Home
- RNW vs PTGX Comparison
RNW vs PTGX Comparison
Compare RNW & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNW | PTGX |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United Kingdom | United States |
| Employees | 4336 | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 5.2B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | RNW | PTGX |
|---|---|---|
| Price | $4.75 | $103.71 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 13 |
| Target Price | $7.00 | ★ $107.38 |
| AVG Volume (30 Days) | 780.1K | ★ 826.9K |
| Earning Date | 02-16-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $873.97 |
| Revenue Next Year | $11.50 | N/A |
| P/E Ratio | $14.63 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.39 | $39.60 |
| 52 Week High | $8.24 | $107.84 |
Technical Indicators
Market Signals| Indicator | RNW | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 37.99 | 61.04 |
| Support Level | $4.39 | $76.63 |
| Resistance Level | $5.58 | N/A |
| Average True Range (ATR) | 0.15 | 4.71 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 41.34 | 74.16 |
Price Performance
Historical ComparisonAbout RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.